Apixaban, an oral direct factor Xa inhibitor, inhibits human clot-bound factor Xa activity in vitro

被引：71
|
作者：
Jiang, Xiaosui [1 ]
Crain, Earl J. [1 ]
Luettgen, Joseph M. [1 ]
Schumacher, William A. [1 ]
Wong, Pancras C. [1 ]
机构：
[1] Bristol Myers Squibb Co, Thrombosis Res, Pennington, NJ 08534 USA
来源：
THROMBOSIS AND HAEMOSTASIS | 2009年 / 101卷 / 04期
关键词：
PROCOAGULANT ACTIVITY; HEPARIN-ANTITHROMBIN; BLOOD-COAGULATION; THROMBOSIS; EFFICACY; INACTIVATION; SAFETY;
D O I：
10.1160/TH08-07-0486
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：780 / 782
页数：3
相关论文
共 50 条
  • [1] Apixaban, an oral direct factor Xa inhibitor, inhibits human clot-bound factor Xa activity in vitro
    Jiang, Xiaosui
    Crain, Earl J.
    Schumacher, William A.
    Wong, Pancras C.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (06) : E137 - E137
  • [2] Edoxaban, an oral direct factor Xa inhibitor, inhibits tissue-factor induced human platelet aggregation and clot-bound factor Xa in vitro
    Morishima, Y.
    Honda, Y.
    Kamisato, C.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 688 - 688
  • [3] Edoxaban, a direct factor Xa inhibitor, suppresses tissue-factor induced human platelet aggregation and clot-bound factor Xa in vitro: Comparison with an antithrombin-dependent factor Xa inhibitor, fondaparinux
    Honda, Yuko
    Kamisato, Chikako
    Morishima, Yoshiyuki
    THROMBOSIS RESEARCH, 2016, 141 : 17 - 21
  • [4] Apixaban: an Oral Direct Factor-Xa Inhibitor
    Jimenez, David
    Yusen, Roger D.
    Ramacciotti, Eduardo
    ADVANCES IN THERAPY, 2012, 29 (03) : 187 - 201
  • [5] Apixaban: an Oral Direct Factor-Xa Inhibitor
    David Jiménez
    Roger D. Yusen
    Eduardo Ramacciotti
    Advances in Therapy, 2012, 29 : 187 - 201
  • [6] Apixaban, an oral, direct inhibitor of activated Factor Xa
    Shantsila, Eduard
    Lip, Gregory Y. H.
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2008, 9 (09) : 1020 - 1033
  • [7] Apixaban, an oral direct Factor Xa inhibitor: awaiting the verdict
    Carreiro, Jennifer
    Ansell, Jack
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2008, 17 (12) : 1937 - 1945
  • [8] Apixaban: an emerging oral factor Xa inhibitor
    Christopher Roser-Jones
    Richard C. Becker
    Journal of Thrombosis and Thrombolysis, 2010, 29 : 141 - 146
  • [9] Apixaban: an emerging oral factor Xa inhibitor
    Roser-Jones, Christopher
    Becker, Richard C.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2010, 29 (01) : 141 - 146
  • [10] Apixaban: A novel oral inhibitor of factor Xa
    Nutescu, Edith
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2012, 69 (13) : 1113 - 1126
12345